All Updates

All Updates

icon
Filter
Product updates
FDA approval
UPSIDE Foods announces new range of ground meat products
Cell-cultured Meat
Apr 20, 2023
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Cell-cultured Meat

Cell-cultured Meat

Apr 20, 2023

UPSIDE Foods announces new range of ground meat products

Product updates
FDA approval

  • California-based cell-cultured meat company UPSIDE Foods (formerly Memphis Meats), has introduced a new range of ground meat products made from animal cells, including chicken sausages, chicken sandwiches, and dumplings. These products are pending regulatory review. 

  • The company has also developed a breakthrough chicken cell line for use in suspension cell culture, which the company claims could substantially reduce the cost of production for these ground meat products.

  • UPSIDE has been working on a range of new meat products including cultivated chicken filets and the next-generation lineup of whole-textured, ground meat products capable of rapid scalability and cost-efficient production. The company plans to initially launch at a small scale with its cultivated chicken filet.

  • The regulatory process for UPSIDE's ground meat products, based on cells grown in suspension culture, will be separate from that of its first product, an adherent tissue-based process for which the company received approval from the US Food and Drug Administration (FDA) last year. UPSIDE notes that it will continue to work with both the FDA and the US Department of Agriculture (USDA) to bring its next generation of products to market. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.